On Tuesday the Sonic Healthcare Limited (ASX: SHL) share price finished the day lower by almost 1% to $21.22.
This brought its three-month decline to over 12%.
Unfortunately for shareholders of the healthcare company, one leading broker doesn't expect its shares to rebound any time soon.
According to a research note out of Credit Suisse, its analysts have retained their underperform rating and lowered the price target on Sonic Healthcare's shares to $21.40.
It analysts appear to believe that recent proposals by Medicare in the United States will negatively impact the company if they get the go ahead.
After all, the company generated 21.5% of its revenue in the country in FY 2017 and Credit Suisse estimates that approximately a fifth of this is funded by Medicare.
While this broker isn't bullish on Sonic Healthcare's prospects, here are three shares that leading brokers think are in the buy zone today.
